What is HCS Pharma?
HCS Pharma is a biotechnology startup headquartered in Loots, France, specializing in in vitro preclinical research and development. Founded in 2014, the company innovates by creating advanced 3D cellular models. These models facilitate phenotypic screening using more relevant 3D cellular assays that incorporate the extracellular matrix (ECM), offering researchers enhanced capabilities for drug discovery and development.
How much funding has HCS Pharma raised?
HCS Pharma has raised a total of $35.5M across 1 funding round:
Share Placement
$35.5M
Share Placement (2021): $35.5M with participation from GEM Global Yield LLC
Key Investors in HCS Pharma
GEM Global Yield LLC
GEM Global Yield LLC is an investment firm that has participated in this significant funding round for HCS Pharma.
What's next for HCS Pharma?
The recent major strategic investment of $35.5M positions HCS Pharma for substantial growth and further development of its innovative 3D cellular modeling technology. This enterprise-level funding is expected to accelerate the company's research and development initiatives, potentially expanding its market reach and solidifying its role in advancing preclinical research methodologies. The strategic nature of this capital infusion suggests a focus on scaling operations and enhancing its competitive edge within the biotechnology landscape.
See full HCS Pharma company page
